315 related articles for article (PubMed ID: 30573048)
41. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
Nováková M; Žaliová M; Suková M; Wlodarski M; Janda A; Froňková E; Campr V; Lejhancová K; Zapletal O; Pospíšilová D; Černá Z; Kuhn T; Švec P; Pelková V; Zemanová Z; Kerndrup G; van den Heuvel-Eibrink M; van der Velden V; Niemeyer C; Kalina T; Trka J; Starý J; Hrušák O; Mejstříková E
Haematologica; 2016 Jun; 101(6):707-16. PubMed ID: 27013649
[TBL] [Abstract][Full Text] [Related]
42. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
Babushok DV; Bessler M; Olson TS
Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
[TBL] [Abstract][Full Text] [Related]
43. Genetic predisposition to MDS: clinical features and clonal evolution.
Kennedy AL; Shimamura A
Blood; 2019 Mar; 133(10):1071-1085. PubMed ID: 30670445
[TBL] [Abstract][Full Text] [Related]
44. De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.
Toki T; Yoshida K; Wang R; Nakamura S; Maekawa T; Goi K; Katoh MC; Mizuno S; Sugiyama F; Kanezaki R; Uechi T; Nakajima Y; Sato Y; Okuno Y; Sato-Otsubo A; Shiozawa Y; Kataoka K; Shiraishi Y; Sanada M; Chiba K; Tanaka H; Terui K; Sato T; Kamio T; Sakaguchi H; Ohga S; Kuramitsu M; Hamaguchi I; Ohara A; Kanno H; Miyano S; Kojima S; Ishiguro A; Sugita K; Kenmochi N; Takahashi S; Eto K; Ogawa S; Ito E
Am J Hum Genet; 2018 Sep; 103(3):440-447. PubMed ID: 30146126
[TBL] [Abstract][Full Text] [Related]
45. Neonatal manifestations of inherited bone marrow failure syndromes.
Khincha PP; Savage SA
Semin Fetal Neonatal Med; 2016 Feb; 21(1):57-65. PubMed ID: 26724991
[TBL] [Abstract][Full Text] [Related]
46. Inherited bone marrow failure syndromes: phenotype as a tool for early diagnostic suspicion at a major reference center in Mexico.
Leal-Anaya P; Kimball TN; Yanez-Felix AL; Fiesco-Roa MÓ; García-de Teresa B; Monsiváis A; Juárez-Velázquez R; Lieberman E; Villarroel C; Yokoyama E; Fernández-Hernández L; Rivera-Osorio A; Sosa D; Ortiz Sandoval MM; López-Santiago N; Frías S; Del Castillo V; Rodríguez A
Front Genet; 2023; 14():1293929. PubMed ID: 38327701
[No Abstract] [Full Text] [Related]
47. Disease progression in recently diagnosed patients with inherited marrow failure syndromes: a Canadian Inherited Marrow Failure Registry (CIMFR) report.
Steele JM; Sung L; Klaassen R; Fernandez CV; Yanofsky R; Wu J; Odame I; Silva M; Champagne J; Ali K; Brossard J; Samson Y; Abish S; Le D; Jardine L; Hand JP; Lipton JH; Charpentier K; Stephens D; Freedman M; Dror Y;
Pediatr Blood Cancer; 2006 Dec; 47(7):918-25. PubMed ID: 16676307
[TBL] [Abstract][Full Text] [Related]
48. Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation.
Durrani J; Groarke EM
Semin Hematol; 2022 Jul; 59(3):137-142. PubMed ID: 36115690
[TBL] [Abstract][Full Text] [Related]
49. Cell senescence and malignant transformation in the inherited bone marrow failure syndromes: Overlapping pathophysiology with therapeutic implications.
Groarke EM; Calado RT; Liu JM
Semin Hematol; 2022 Jan; 59(1):30-37. PubMed ID: 35491056
[TBL] [Abstract][Full Text] [Related]
50. How I diagnose myeloid neoplasms with germline predisposition.
Patel N; Calvo KR
Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
[TBL] [Abstract][Full Text] [Related]
51. Aplastic Anemia, Pediatric Aspects.
Alter BP
Oncologist; 1996; 1(6):361-366. PubMed ID: 10388017
[TBL] [Abstract][Full Text] [Related]
52. Current diagnosis of inherited bone marrow failure syndromes.
Tamary H; Alter BP
Pediatr Hematol Oncol; 2007 Mar; 24(2):87-99. PubMed ID: 17454774
[TBL] [Abstract][Full Text] [Related]
53. p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia.
Elghetany MT; Alter BP
Arch Pathol Lab Med; 2002 Apr; 126(4):452-5. PubMed ID: 11900571
[TBL] [Abstract][Full Text] [Related]
54. Pathogenesis of aplastic anemia.
Wang L; Liu H
Hematology; 2019 Dec; 24(1):559-566. PubMed ID: 31315542
[TBL] [Abstract][Full Text] [Related]
55. Rare anemias from the group of congenital bone marrow failure syndromes.
Pospíšilová D
Vnitr Lek; 2018; 64(5):488-500. PubMed ID: 30193517
[TBL] [Abstract][Full Text] [Related]
56. Current insights into inherited bone marrow failure syndromes.
Chung NG; Kim M
Korean J Pediatr; 2014 Aug; 57(8):337-44. PubMed ID: 25210520
[TBL] [Abstract][Full Text] [Related]
57. Nonsense Suppression Therapy: New Hypothesis for the Treatment of Inherited Bone Marrow Failure Syndromes.
Bezzerri V; Api M; Allegri M; Fabrizzi B; Corey SJ; Cipolli M
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630050
[TBL] [Abstract][Full Text] [Related]
58. [Bone marrow failure].
Drexler B; Tichelli A; Passweg JR
Ther Umsch; 2019; 76(9):523-529. PubMed ID: 32157970
[TBL] [Abstract][Full Text] [Related]
59. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
Mangaonkar AA; Patnaik MM
Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604
[TBL] [Abstract][Full Text] [Related]
60. Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
Martin ES; Ferrer A; Mangaonkar AA; Khan SP; Kohorst MA; Joshi AY; Hogan WJ; Olteanu H; Moyer AM; Al-Kali A; Tefferi A; Chen D; Wudhikarn K; Go R; Viswanatha D; He R; Ketterling R; Nguyen PL; Oliveira JL; Gangat N; Lasho T; Patnaik MM
Am J Hematol; 2021 Nov; 96(11):1450-1460. PubMed ID: 34390506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
